Central Incisors Narrow Implants in Alternative to Bone Augmentation With 4.2 mm Implants .
NCT ID: NCT02897193
Last Updated: 2019-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
42 participants
INTERVENTIONAL
2016-08-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The comparison between these two solutions will be evaluated in the trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short Implants - An Alternative to Bone Grafting?
NCT01030523
Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration
NCT03225495
Localized Alveolar Ridge Augmentation With Space Maintenance Devices
NCT00991432
Wedge Implant Narrow Crests: Multi-center Clinical Study
NCT03290729
The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges
NCT03468998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dental implant with bone augmentation
patients will be installed with ICE Dental implant 4.2 mm diameter with Alpha-Bio's grafts horizontal bone augmentation
ICE dental implant 4.2 mm
ICE dental implant 4.2 mm diameter
Alpha Bio's Graft Bovine bone
Alpha Bio's Graft Bovine Bone
Alpha Bio's Graft resorbable membrane
Alpha Bio's Graft resorbable collagen membrane
narrow implant
patients will be installed with NICE Dental implant 3.2 mm diameter
NICE dental implant 3.2 mm
NICE dental implant 4.2 mm diameter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICE dental implant 4.2 mm
ICE dental implant 4.2 mm diameter
NICE dental implant 3.2 mm
NICE dental implant 4.2 mm diameter
Alpha Bio's Graft Bovine bone
Alpha Bio's Graft Bovine Bone
Alpha Bio's Graft resorbable membrane
Alpha Bio's Graft resorbable collagen membrane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* bone width between 3.5-4.5 mm
* requirement of only one implant supported crown
* patient is willing to sign an informed consent
Exclusion Criteria
* Immunosuppressed or immunocompromised patients
* Patients irradiated in the head and neck area.
* Patients with poor oral hygiene and motivation.
* Uncontrolled diabetes.
* Pregnancy or lactation.
* Addiction to alcohol or drugs.
* Untreated periodontal disease.
* Treated or under treatment with intravenous amino-biphosphonates.
* Poor oral hygiene and motivation.
* Psychiatric problems and/or unrealistic expectations.
* Acute infection (abscess) or suppuration in the area intended for implant placement.
* Patients referred only for implant placement if cannot be followed at the treatment centre.
* Patient unable to attend the follow-up controls for 3 years after implant loading.
* Patient included in other studies, if this protocol cannot be properly followed.
* Immediate post-extractive sites (to be eligible at least 3 months must have passed since extraction).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alpha - Bio Tec Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Antofagasta
Antofagasta, , Chile
Andrés Bello National University
Santiago, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
sponsor site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABT-ME-130815
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.